SCHEMBL3377852

SCHEMBL3377852

CCC(C)NC(=O)c1c(OS(=O)(=O)CC)cccc1C(=O)O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.48
KMT2A Q03164 3/20 0.48
ALDH1A1 P00352 2/20 0.43
RAB9A P51151 1/20 0.43
PKM P14618 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
HPGD P15428 3/20 0.40
CA12 O43570 2/20 0.39
CA1 P00915 2/20 0.39
CA2 P00918 2/20 0.39
CA9 Q16790 2/20 0.39
MAPK1 P28482 1/20 0.39
KDM4E B2RXH2 4/20 0.38
HSD17B10 Q99714 2/20 0.38
FPR1 P21462 1/20 0.38
EPHX2 P34913 2/20 0.37
CYP1A2 P05177 1/20 0.37
CYP2C9 P11712 1/20 0.37
TSHR P16473 1/20 0.37
MAPT P10636 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3373245 0.92 KDM4E (0.39) MEN1KMT2AALDH1A1HPGDMAPK1
SCHEMBL3377959 0.91 MEN1 (0.39) MEN1KMT2AALDH1A1RAB9ASMN1; SMN2
SCHEMBL3377855 0.90 MEN1 (0.51) MEN1KMT2AALDH1A1RAB9APKM
SCHEMBL3377825 0.90 MEN1 (0.48) MEN1KMT2AALDH1A1RAB9APKM
SCHEMBL3373446 0.87 MEN1 (0.45) MEN1KMT2AALDH1A1RAB9APKM
SCHEMBL3374465 0.84 POLB (0.44) MEN1KMT2ASMN1; SMN2HPGDKDM4E
SCHEMBL3373248 0.82 MEN1 (0.40) MEN1KMT2AALDH1A1HPGDCA12
SCHEMBL551637 0.82 ALDH1A1 (0.45) MEN1KMT2AALDH1A1RAB9ASMN1; SMN2
SCHEMBL3377960 0.81 MEN1 (0.41) MEN1KMT2AALDH1A1RAB9ASMN1; SMN2
SCHEMBL3378393 0.81 CA12 (0.43) MEN1KMT2AALDH1A1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1517886-B1 NOVEL PHTHALAMIDE DERIVATIVES BAYER CROPSCIENCE AG (DE) 2010-11-10 EP disclosed
US-7132455-B2 Phthalamide derivatives BAYER CROPSCIENCE AG (DE) 2006-11-07 US disclosed
US-20060035967-A1 Novel phthalamide derivatives BAYER INTELLECTUAL PROPERTY GMBH (DE) 2006-02-16 US disclosed
EP-1517886-A1 NOVEL PHTHALAMIDE DERIVATIVES Bayer CropScience AG (DE) 2005-03-30 EP disclosed
WO-2004000796-A1 NOVEL PHTHALAMIDE DERIVATIVES BAYER CROPSCIENCE AG (DE) 2003-12-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060035967-A1 Novel phthalamide derivatives HDAC1, HDAC2, CRY1 MEN1 1772/4885KMT2A 102/4885ALDH1A1 1071/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.